Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Has results × Janus Kinase Inhibitors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 449 Bevacizumab 438 Carboplatin 378 Paclitaxel 333 Gemcitabine 323 Cisplatin 314 pembrolizumab 313 Docetaxel 284 Rituximab 281 Radiotherapy 269 Nivolumab 210 Doxorubicin 210 Dexamethasone 206 Fluorouracil 202 Capecitabine 191 Oxaliplatin 189 Erlotinib Hydrochloride 176 fludarabine phosphate 172 Etoposide 165 Pemetrexed 157 Cetuximab 154 Bortezomib 153 Lenalidomide 152 Leucovorin 150 Trastuzumab 148 Filgrastim 148 fludarabine 147 Irinotecan 146 Prednisone 144 Cytarabine 143

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04404361 2024-06-05

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

CTI BioPharma

Phase 2 Terminated

200 enrolled 16 charts

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon ⚡